LV10924B - Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease - Google Patents

Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease Download PDF

Info

Publication number
LV10924B
LV10924B LVP-95-158A LV950158A LV10924B LV 10924 B LV10924 B LV 10924B LV 950158 A LV950158 A LV 950158A LV 10924 B LV10924 B LV 10924B
Authority
LV
Latvia
Prior art keywords
salen
metal complex
group
antioxidant
antioxidant salen
Prior art date
Application number
LVP-95-158A
Other languages
English (en)
Latvian (lv)
Other versions
LV10924A (lv
Inventor
Bernard Malfroy-Camine
Michel Baudry
Original Assignee
Eukarion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eukarion Inc filed Critical Eukarion Inc
Publication of LV10924A publication Critical patent/LV10924A/xx
Publication of LV10924B publication Critical patent/LV10924B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Hydrogenated Pyridines (AREA)
LVP-95-158A 1992-12-07 1995-06-06 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease LV10924B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/987,474 US5403834A (en) 1992-12-07 1992-12-07 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
PCT/US1993/011857 WO1994013300A1 (en) 1992-12-07 1993-12-06 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

Publications (2)

Publication Number Publication Date
LV10924A LV10924A (lv) 1995-12-20
LV10924B true LV10924B (en) 1996-10-20

Family

ID=25533292

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-158A LV10924B (en) 1992-12-07 1995-06-06 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

Country Status (20)

Country Link
US (2) US5403834A (de)
EP (2) EP1642583A2 (de)
JP (1) JP3502099B2 (de)
KR (1) KR20040004386A (de)
AT (1) ATE290867T1 (de)
AU (1) AU697399B2 (de)
CA (1) CA2150937C (de)
CZ (1) CZ296288B6 (de)
DE (1) DE69333775T2 (de)
GB (2) GB2277873B (de)
HU (1) HU225109B1 (de)
LV (1) LV10924B (de)
NO (1) NO319454B1 (de)
NZ (1) NZ259200A (de)
OA (1) OA10165A (de)
PL (1) PL175446B1 (de)
RU (1) RU2157213C2 (de)
SK (1) SK74595A3 (de)
UA (1) UA27949C2 (de)
WO (1) WO1994013300A1 (de)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5653685A (en) * 1990-10-10 1997-08-05 Lrt, Inc. Method of providing circulation via lung expansion and deflation
USRE36460E (en) * 1990-10-10 1999-12-21 Life Science Holdings, Inc. Method of providing circulation via lung expansion and deflation
US7582786B2 (en) * 1992-12-07 2009-09-01 Eukarion Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5696109A (en) * 1992-12-07 1997-12-09 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5834509A (en) * 1992-12-07 1998-11-10 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5403834A (en) * 1992-12-07 1995-04-04 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5686436A (en) * 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
BR9507643A (pt) * 1994-05-13 1997-09-23 Monsanto Co Métodos de uso para catalisadores de decomposição de peroxinitrito composições farmacéuticas para os mesmos
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
WO1996004311A1 (en) * 1994-08-03 1996-02-15 University Of Alabama At Birmingham Research Foundation Monoclonal antibody to nitrotyrosine, methods for diagnosis and methods for treatment of disease
US5900433A (en) * 1995-06-23 1999-05-04 Cormedics Corp. Vascular treatment method and apparatus
US5927273A (en) * 1996-03-08 1999-07-27 Life Resuscitation Technologies, Inc. Combined liquid ventilation and cardiopulmonary resuscitation method
AU4258097A (en) 1996-09-06 1998-03-26 Duke University Methods for testing compounds for use as therapeutic antioxidants
US6369106B1 (en) * 1996-12-26 2002-04-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
US6214817B1 (en) 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
US5834178C1 (en) * 1997-07-09 2002-04-23 Univ Wayne State Flush-storage solution for donor organs
US5829449A (en) * 1997-09-19 1998-11-03 Thione International, Inc. Smoking products containing antioxidants
AT409306B (de) * 1997-10-03 2002-07-25 Hoffmann La Roche Optisch chemischer sensor
IL135949A0 (en) 1997-11-03 2001-05-20 Univ Duke Substituted porphyrins
CA2249778A1 (en) * 1997-12-15 1999-06-15 Bayer Corporation Competitive apo-peroxidase assay
GB9817845D0 (en) 1998-08-17 1998-10-14 Glaxo Group Ltd Chemical compounds
US7816403B2 (en) * 1998-09-08 2010-10-19 University Of Utah Research Foundation Method of inhibiting ATF/CREB and cancer cell growth and pharmaceutical compositions for same
US6703384B2 (en) * 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
SE9803710L (sv) * 1998-09-25 2000-03-26 A & Science Invest Ab Användning av vissa substanser för behandling av nervrotsskador
RU2162698C2 (ru) * 1998-10-29 2001-02-10 НИИ психического здоровья Томского научного центра СО РАМН Способ повышения устойчивости к гемолизу эритроцитов и восстановления их поврежденной формы
DK1616869T3 (da) 1999-01-25 2012-05-07 Nat Jewish Health Substituerede porphyriner og deres terapeutiske anvendelse
US6365385B1 (en) 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
US6303355B1 (en) 1999-03-22 2001-10-16 Duke University Method of culturing, cryopreserving and encapsulating pancreatic islet cells
US20040110722A1 (en) * 1999-05-27 2004-06-10 Ornberg Richard L. Modified hyaluronic acid polymers
DE60018925T2 (de) 1999-05-27 2006-04-13 Pharmacia Corp.(N.D.Ges.D.Staates Delaware) Biomaterialien, modifiziert mit superoxid-dismutase imitatoren
US6179804B1 (en) * 1999-08-18 2001-01-30 Oxypatch, Llc Treatment apparatus for wounds
KR100847678B1 (ko) * 2000-02-11 2008-07-23 리서치 디벨럽먼트 파운데이션 토코페롤, 토코트리에놀, 다른 크로만 및 측쇄 유도체, 및이들의 용도
US20040047852A1 (en) * 2001-03-02 2004-03-11 Kennedy Thomas Preston Method of treating cancer
US20030069281A1 (en) * 2000-06-14 2003-04-10 Irwin Fridovich Tetrapyrroles
AU2002220121A1 (en) * 2000-11-28 2002-06-11 Lorillard Licensing Company, Llc A smoking article including a selective carbon monoxide pump
US6589948B1 (en) 2000-11-28 2003-07-08 Eukarion, Inc. Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
US6481442B1 (en) 2000-11-28 2002-11-19 Lorillard Licensing Company, Llc Smoking article including a filter for selectively removing carbonyls
US6692458B2 (en) * 2000-12-19 2004-02-17 Edwards Lifesciences Corporation Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis
EP1392328B1 (de) * 2001-01-19 2009-08-12 National Jewish Medical and Research Center Medikament zum schutz in der radiotherapie
ITPI20010014A1 (it) * 2001-03-05 2002-09-05 Ivo Pera Composto per filtri per sigarette,o altri articoli da fumo,a base di sostanze antiossidanti ed il filtro cosi'ottenuto
KR100681326B1 (ko) * 2001-04-20 2007-02-15 주식회사 중외제약 신규한 망간-키랄성 화합물 및 그의 이용방법
EP1253131A1 (de) * 2001-04-24 2002-10-30 Aventis Animal Nutrition S.A. Verfahren zur Herstellung eines Xanthophylls
AU2002312194B8 (en) * 2001-06-01 2008-05-15 Aeolus Sciences, Inc. Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
WO2003010143A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
WO2003010154A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010153A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
RU2223790C2 (ru) * 2001-10-25 2004-02-20 ГФУН "Российский научно-исследовательский институт травматологии и ортопедии им. Р.Р. Вредена" Способ стерилизации биологических трансплантатов окисью этилена в жидкой среде
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
EP1463487B1 (de) * 2001-12-19 2010-05-19 Research Development Foundation Liposomale abgabe von verbindungen auf vitamin-e-basis
RU2223493C2 (ru) * 2002-01-22 2004-02-10 В/ч 61469 МО РФ Способ определения вероятной токсичности ксенобиотиков применительно к человеку
AU2003237500A1 (en) * 2002-06-07 2003-12-22 Duke University Substituted porphyrins
US6835387B2 (en) 2002-06-11 2004-12-28 Scimed Life Systems, Inc. Sustained release of superoxide dismutase mimics from implantable or insertable medical devices
US20040132789A1 (en) * 2002-08-22 2004-07-08 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
US20040044220A1 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
CN103405405A (zh) 2002-12-09 2013-11-27 阿布拉西斯生物科学有限责任公司 组合物和传递药剂的方法
RU2361615C2 (ru) * 2002-12-09 2009-07-20 Абраксис Байосайенс, Ллс. Композиции и способы доставки фармакологических агентов
WO2004052098A1 (en) * 2002-12-11 2004-06-24 Cryolife, Inc. Radical retardant cryopreservation solutions
RU2246297C2 (ru) * 2003-02-19 2005-02-20 Пятигорская государственная фармацевтическая академия Желатиновые капсулы "гастробиол-цд" на основе клатратов концентрата облепихового масла, обладающие противоязвенным действием
RU2246248C1 (ru) * 2003-06-16 2005-02-20 Ростовский научно-исследовательский онкологический институт МЗ РФ Способ прогнозирования развития метахронного рака молочной железы
WO2005030137A2 (en) * 2003-09-24 2005-04-07 The University Of Toledo, A University Instrumentality Of The State Of Ohio Improving biomechanical performance of irradiated biological material
US20050100537A1 (en) * 2003-11-10 2005-05-12 Evans Gregory S. Methods and kits for reducing cellular damage, inhibiting free radical production, and scavenging free radicals in mammals
WO2006078713A2 (en) * 2005-01-19 2006-07-27 Metaphore Pharmaceuticals, Inc. Methotrexate combinations for treating inflammatory diseases
KR101159392B1 (ko) * 2005-05-04 2012-06-28 코티 프레스티지 랭카스터 그룹 게엠베하 화학요법에 의해 야기되는 피부 및 모발의 손상을 예방또는 치료하기 위한 용도를 지닌 유리-라디칼 스캐빈저
RU2318500C2 (ru) * 2005-10-18 2008-03-10 Общество С Ограниченной Ответственностью "Митотехнология" Способ воздействия на организм путем адресной доставки биологически активных веществ в митохондрии, фармацевтическая композиция для его осуществления и соединение, применяемое для этой цели
RU2290176C1 (ru) * 2005-12-01 2006-12-27 Общество С Ограниченной Ответственностью "Акцент" Устойчивая водно-масляная композиция на основе 6-декапренил-2,3-диметокси-5-метил-1,4-бензохинона и способ ее получения
EP2345974B1 (de) * 2006-06-28 2014-08-06 IHI Corporation Magnetisch führbare Verbindung
WO2008070557A2 (en) * 2006-12-01 2008-06-12 Women & Infants Hospital Organometallic complexes as therapeutic agents
RU2364396C2 (ru) * 2007-11-07 2009-08-20 ФГУН "Нижегородский научно-исследовательский институт гигиены и профессиональной патологии" Роспотребнадзора Способ профилактики и коррекции иммунных нарушений, вызываемых токсическими веществами
US20090169484A1 (en) 2007-12-28 2009-07-02 Ihi Corporation Iron-salen complex
US11382895B2 (en) 2008-05-23 2022-07-12 National Jewish Health Methods for treating injury associated with exposure to an alkylating species
JP5513405B2 (ja) * 2008-11-20 2014-06-04 株式会社Ｉｈｉ 自己磁性金属サレン錯体化合物
KR101050273B1 (ko) * 2008-11-21 2011-07-19 세종대학교산학협력단 살렌 전이금속 착화합물, 및 그 제조 방법
WO2011125331A1 (ja) * 2010-04-06 2011-10-13 株式会社Ihi 金属サレン錯体誘導体及びその製造方法
US8933118B2 (en) 2010-04-28 2015-01-13 Ihi Corporation Anti-brain-tumor drug
WO2011151978A1 (ja) * 2010-06-01 2011-12-08 株式会社Ihi 蛍光色素材料及びその使用方法
CN103517895A (zh) * 2010-12-21 2014-01-15 株式会社Ihi 金属沙仑配位化合物及其制造方法
JP5873656B2 (ja) * 2011-06-13 2016-03-01 株式会社Ihi 金属サレン錯体化合物、局所麻酔薬剤及び抗悪性腫瘍薬剤
JP6017766B2 (ja) 2011-07-26 2016-11-02 株式会社Ihi 新規な金属サレン錯体化合物の抗がん剤
RU2595840C2 (ru) * 2011-10-04 2016-08-27 АйЭйчАй КОРПОРЕЙШН Лекарственное средство, чувствительное к комплексному соединению металл-сален, и система регуляции интракорпорального свойства для комплексного соединения металл-сален
JP6046338B2 (ja) * 2011-10-27 2016-12-14 株式会社Ihi ラジカル抑制剤
US9187509B2 (en) * 2012-01-05 2015-11-17 Pled Pharma AB Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment
CN108030926B (zh) * 2017-12-15 2021-07-13 武汉工程大学 一种具有高的SOD酶活性的Salen型锰配合物-壳聚糖复合材料及其制备方法
RU2699040C1 (ru) * 2018-07-23 2019-09-03 Федеральное государственное бюджетное учреждение науки "Уральский научно-практический центр радиационной медицины Федерального медико-биологического агентства" (ФГБУН УНПЦ РМ ФМБА России) Способ экстренной профилактики и лечения острой лучевой болезни (варианты)
WO2025073823A1 (en) * 2023-10-03 2025-04-10 Aarhus Universitet Antioxidant microgels for liver diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US5106841A (en) * 1986-05-13 1992-04-21 Chai-Tech Corporation Antiviral compositions and method for their use
US5223538A (en) * 1987-03-31 1993-06-29 Duke University Superoxide dismutase mimic
AU678139B2 (en) * 1991-08-26 1997-05-22 Research Corporation Technologies, Inc. Method of enantio selectively epoxidizing cinnamate derivatives
US5403834A (en) * 1992-12-07 1995-04-04 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

Also Published As

Publication number Publication date
NO319454B1 (no) 2005-08-15
CA2150937C (en) 2007-08-14
PL309334A1 (en) 1995-10-02
GB9621087D0 (en) 1996-11-27
CA2150937A1 (en) 1994-06-23
EP0746321A4 (de) 2001-05-09
LV10924A (lv) 1995-12-20
CZ144295A3 (en) 1996-10-16
DE69333775D1 (de) 2005-04-21
WO1994013300A1 (en) 1994-06-23
NZ259200A (en) 1997-06-24
UA27949C2 (uk) 2000-10-16
NO952237D0 (no) 1995-06-06
KR20040004386A (ko) 2004-01-13
DE69333775T2 (de) 2006-04-06
RU2157213C2 (ru) 2000-10-10
EP0746321B1 (de) 2005-03-16
GB2305107B (en) 1997-05-14
HUT72967A (en) 1996-06-28
JPH08504211A (ja) 1996-05-07
US5827880A (en) 1998-10-27
HU225109B1 (en) 2006-06-28
ATE290867T1 (de) 2005-04-15
AU5741994A (en) 1994-07-04
OA10165A (en) 1996-12-18
HU9501644D0 (en) 1995-08-28
GB2277873A (en) 1994-11-16
GB2277873B (en) 1997-05-14
GB9415050D0 (en) 1994-09-14
AU697399B2 (en) 1998-10-08
US5403834A (en) 1995-04-04
NO952237L (no) 1995-08-01
PL175446B1 (pl) 1998-12-31
EP0746321A1 (de) 1996-12-11
SK74595A3 (en) 1996-05-08
CZ296288B6 (cs) 2006-02-15
GB2305107A (en) 1997-04-02
EP1642583A2 (de) 2006-04-05
JP3502099B2 (ja) 2004-03-02

Similar Documents

Publication Publication Date Title
EP0746321B1 (de) Synthetische katalytische freie radikalfänger, verwendbar als antioxidantien zur prävention und therapie von krankheiten
WO1994013300A9 (en) Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US6900198B2 (en) Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US6589948B1 (en) Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
US5834509A (en) Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
AU2002239381A1 (en) Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
US7582786B2 (en) Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease